1477-68-5
![1477-68-5 結(jié)構(gòu)式](/CAS/GIF/1477-68-5.gif)
基本信息
甲氧酩胺鹽酸鹽
3-甲氧基色胺
甲基多巴胺鹽酸鹽
3-甲氧基色胺鹽酸鹽
3-甲氧基酪胺鹽酸鹽
3-O-甲基多巴胺鹽酸鹽
3-甲氧基-4-羥基苯乙胺
甲醇中甲氧酩胺溶液標(biāo)準(zhǔn)物質(zhì)
3-甲氧基色胺鹽酸鹽 1ML
3-METHOXYTYRAMINE
RARECHEM AL BW 0216
TIMTEC-BB SBB000426
TIMTEC-BB SBB003882
2-ethyl-d4-aMine HCl
3-METHOXYTYRAMINE HCL
3-O-Methyldopamine HCL
MethoxytyraMine solution
3-Methoxy-p-tyraMine HCl
物理化學(xué)性質(zhì)
安全數(shù)據(jù)
制備方法
報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
2025/02/08 | HY-103638A | 2-甲氧基-4-(2-氨基乙基)苯酚 3-Methoxytyramine | 1477-68-5 | 100mg | 500元 |
2025/02/08 | HY-103638 | 2-甲氧基-4-(2-氨基乙基)苯酚 3-Methoxytyramine hydrochloride | 1477-68-5 | 100mg | 100元 |
2025/02/08 | HY-103638A | 2-甲氧基-4-(2-氨基乙基)苯酚 3-Methoxytyramine | 1477-68-5 | 10 mM * 1 mLin DMSO | 550元 |
常見問題列表
Human Endogenous Metabolite
|
The intensity of the fluorescence developed is in a linear relation to the amount of 3-Methoxytyramine hydrochloride presented in the sample up to at least 1 μg. When a high concentration of dopamine is present in the reaction mixture, there is some reduction in the fluorescence derived from 3-Methoxytyramine hydrochloride.
The extracellular DA metabolite 3-Methoxytyramine hydrochloride (3-MT) induces significant behavioral activation in DDD mice. This activity however, is mostly presented as a set of disorganized abnormal movements that includes tremor, head bobbing, straub tail, grooming and abnormal orofacial movements rather than normal forward activity. No effect is observed when 3-Methoxytyramine hydrochloride is infused at doses below 9 μg, at 9 μg and higher doses 3-Methoxytyramine hydrochloride dose-dependently causes transient behavioral activation with a complex set of behaviors. In particular, transient hyperactivity and stereotypy, sniffing, grooming, rearing and mild abnormal involuntary movements (AIMs) at the level of limbs is observed after infusion of 9 μg of 3-Methoxytyramine hydrochloride. Similar behaviors are also observed after 18 μg of 3-Methoxytyramine hydrochloride with the additional appearance of tremor as well as oral and whole body AIMs.